Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness

Transfusion

Volumn 57, Issue 1, 2017, Pages 195-206

  Muszynski, Jennifer A ^a   Spinella, Philip C ^a   Cholette, Jill M ^a   Acker, Jason P ^a,e   Hall, Mark W ^a   Juffermans, Nicole P ^f   Kelly, Daniel P ^g   Blumberg, Neil ^d   Nicol, Kathleen ^b   Liedel, Jennifer ^h   Doctor, Allan ^c   Remy, Kenneth E ^a   Tucci, Marisa ⁱ   Lacroix, Jacques ⁱ   Norris, Philip J ^j,k  

^a CANADIAN BLOOD SERVICES   (Canada)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

ⁱ UNIVERSITY OF MONTREAL   (Canada)

^j BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; CHILD; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EPIDEMIOLOGICAL DATA; ERYTHROCYTE TRANSFUSION; GROUPS BY AGE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; INTENSIVE CARE UNIT; NONHUMAN; PHENOTYPE; PLASMA TRANSFUSION; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TRANSFUSION RELATED IMMUNOMODULATION; ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD COMPONENT THERAPY; FEMALE; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD COMPONENT TRANSFUSION; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; FEMALE; HUMANS; IMMUNOMODULATION; INFANT; INFLAMMATION; INTENSIVE CARE UNITS; MALE;

EID: 84994910669     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13855     Document Type: Review

References (122)

1. Keown PA, Descamps B. Improved renal allograft survival after blood transfusion: a nonspecific, erythrocyte-mediated immunoregulatory process? Lancet 1979;1:20–2.
2. Belizaire RM, Prakash PS, Richter JR, et al. Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J Am Coll Surg 2012;214:648–55; discussion 656-7.
3. Shaz BH, Stowell SR, Hillyer CD. Transfusion-related acute lung injury: from bedside to bench and back. Blood 2011;117:1463–71.
4. Silliman CC, Moore EE, Kelher MR, et al. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 2011;51:2549–54.
5. Doughty L, Carcillo JA, Kaplan S, et al. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 1998;113:1625–31.
6. Hall MW, Geyer SM, Guo CY, et al. Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med 2013;41:224–36.
7. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med 2007;167:1655–63.
8. Muszynski JA, Nofziger R, Greathouse K, et al. Innate immune function predicts the development of nosocomial infection in critically injured children. Shock 2014;42:313–21.
9. Wong HR, Cvijanovich N, Wheeler DS, et al. Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008;178:276–82.
10. Green J, Doughty L, Kaplan SS, et al. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure. Thromb Haemost 2002;87:218–23.
11. Döcke WD, Höflich C, Davis KA, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem 2005;51:2341–7.
12. Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 2011;37:525–32.
13. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175–83.
14. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation–rationale for a new therapeutic strategy in sepsis. Intensive Care Med 1996;22:S474–81.
15. Cornell TT, Sun L, Hall MW, et al. Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2012;143:1160–6.e1.
16. Döcke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997;3:678–81.
17. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011;306:2594–605.
18. Felmet KA, Hall MW, Clark RS, et al. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005;174:3765–72.
19. Hotchkiss RS, Chang KC, Swanson PE, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000;1:496–501.
20. Muszynski JA, Nofziger R, Greathouse K, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care 2014;18:R145.
21. Westendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170–3.
22. Hall MW. Immune balance in critical illness: SIRS, CARS, immunoparalysis. In: Zimmerman FA, editor. Pediatric critical care. 5th ed. Philadelphia: Elsevier; 2016.
23. Bateman ST, Lacroix J, Boven K, et al. Anemia, blood loss, and blood transfusions in North American children in the intensive care unit. Am J Respir Crit Care Med 2008;178:26–33.
24. Dallman MD, Liu X, Harris AD, et al. Changes in transfusion practice over time in the PICU. Pediatr Crit Care Med 2013;14:843–50.
25. Demaret P, Tucci M, Ducruet T, et al. Red blood cell transfusion in critically ill children (CME). Transfusion 2014;54:365–75; quiz 364.
26. Valentine SL, Lightdale JR, Tran CM, et al. Assessment of hemoglobin threshold for packed RBC transfusion in a medical-surgical PICU. Pediatr Crit Care Med 2014;15:e89–94.
27. Karam O, Demaret P, Shefler A, et al. Indications and effects of plasma transfusions in critically ill children. Am J Respir Crit Care Med 2015;191:1395–402.
28. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36:2667–74.
29. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453–62.
30. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010;304:1559–67.
31. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409–17.
32. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227–34.
33. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11–21.
34. Walsh TS, Boyd JA, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013;41:2354–63.
35. Carson JL, Carless PA, Hébert PC. Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 2013;309:83–4.
36. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med 2012;157:49–58.
37. Holst LB, Petersen MW, Haase N, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ 2015;350:h1354.
38. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014;127:124–31.e3.
39. Goodman AM, Pollack MM, Patel KM, et al. Pediatric red blood cell transfusions increase resource use. J Pediatr 2003;142:123–7.
40. Kneyber MC, Hersi MI, Twisk JW, et al. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007;33:1414–22.
41. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007;356:1609–19.
42. Karam O, Tucci M, Ducruet T, et al. Red blood cell transfusion thresholds in pediatric patients with sepsis. Pediatr Crit Care Med 2011;12:512–8.
43. Rouette J, Trottier H, Ducruet T, et al. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: a randomized clinical trial. Ann Surg 2010;251:421–7.
44. Willems A, Harrington K, Lacroix J, et al. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Crit Care Med 2010;38:649–56.
45. Cholette JM, Rubenstein JS, Alfieris GM, et al. Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy. Pediatr Crit Care Med 2011;12:39–45.
46. de Gast-Bakker DH, de Wilde RB, Hazekamp MG, et al. Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. Intensive Care Med 2013;39:2011–9.
47. Istaphanous GK, Wheeler DS, Lisco SJ, et al. Red blood cell transfusion in critically ill children: a narrative review. Pediatr Crit Care Med 2011;12:174–83.
48. Parker RI. Transfusion in critically ill children: indications, risks, and challenges. Crit Care Med 2014;42:675–90.
49. Secher EL, Stensballe J, Afshari A. Transfusion in critically ill children: an ongoing dilemma. Acta Anaesthesiol Scand 2013;57:684–91.
50. Tyrrell CT, Bateman ST. Critically ill children: to transfuse or not to transfuse packed red blood cells, that is the question. Pediatr Crit Care Med 2012;13:204–9.
51. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513–6.
52. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973.
53. Taylor RW, Manganaro L, O'Brien J, et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med 2002;30:2249–54.
54. Vamvakas EC, Carven JH. Exposure to allogeneic plasma and risk of postoperative pneumonia and/or wound infection in coronary artery bypass graft surgery. Transfusion 2002;42:107–13.
55. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998;97:562–8.
56. Vamvakas EC. Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 2002;16:144–60.
57. Tan TW, Farber A, Hamburg NM, et al. Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg 2013;216:1005–14.e2; quiz 1031-3.
58. Woods BI, Rosario BL, Chen A, et al. The association between perioperative allogeneic transfusion volume and postoperative infection in patients following lumbar spine surgery. J Bone Joint Surg Am 2013;95:2105–10.
59. Bochicchio GV, Napolitano L, Joshi M, et al. Blood product transfusion and ventilator-associated pneumonia in trauma patients. Surg Infect (Larchmt) 2008;9:415–22.
60. Hill GE, Frawley WH, Griffith KE, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 2003;54:908–14.
61. Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? Intensive Care Med 2013;39:445–53.
62. Rachoin JS, Daher R, Schorr C, et al. Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion. Vox Sang 2009;97:294–302.
63. Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 2014;311:1317–26.
64. Elward AM, Fraser VJ. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study. Infect Control Hosp Epidemiol 2006;27:553–60.
65. White M, Barron J, Gornbein J, et al. Are red blood cell transfusions associated with nosocomial infections in pediatric intensive care units? Pediatr Crit Care Med 2010;11:464–8.
66. Jeschke MG, Chinkes DL, Finnerty CC, et al. Blood transfusions are associated with increased risk for development of sepsis in severely burned pediatric patients. Crit Care Med 2007;35:579–83.
67. Kneyber MC, Grotenhuis F, Berger RF, et al. Transfusion of leukocyte-depleted RBCs is independently associated with increased morbidity after pediatric cardiac surgery. Pediatr Crit Care Med 2013;14:298–305.
68. Székely A, Cserép Z, Sápi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg 2009;87:187–97.
69. Kleiber N, Lefebvre E, Gauvin F, et al. Respiratory dysfunction associated with RBC transfusion in critically ill children: a prospective cohort study. Pediatr Crit Care Med 2015;16:325–34.
70. Lieberman L, Petraszko T, Yi QL, et al. Transfusion-related lung injury in children: a case series and review of the literature. Transfusion 2014;54:57–64.
71. Mulder HD, Augustijn QJ, van Woensel JB, et al. Incidence, risk factors, and outcome of transfusion-related acute lung injury in critically ill children: a retrospective study. J Crit Care 2015;30:55–9.
72. Roubinian NH, Looney MR, Kor DJ, et al. Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions. Transfusion 2015;55:1838–46.
73. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327–48.
74. Cholette JM, Pietropaoli AP, Henrichs KF, et al. Longer RBC storage duration is associated with increased postoperative infections in pediatric cardiac surgery. Pediatr Crit Care Med 2015;16:227–35.
75. Gauvin F, Spinella PC, Lacroix J, et al. Association between length of storage of transfused red blood cells and multiple organ dysfunction syndrome in pediatric intensive care patients. Transfusion 2010;50:1902–13.
76. Karam O, Tucci M, Toledano BJ, et al. Length of storage and in vitro immunomodulation induced by prestorage leukoreduced red blood cells. Transfusion 2009;49:2326–34.
77. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015;314:2514–23.
78. Fergusson DA, Hébert P, Hogan DL, et al. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012;308:1443–51.
79. Lacroix J, Hébert PC, Fergusson DA, et al. Age of transfused blood in critically ill adults. N Engl J Med 2015;372:1410–8.
80. Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015;372:1419–29.
81. Muszynski JA, Frazier E, Nofziger R, et al. Red blood cell transfusion and immune function in critically ill children: a prospective observational study. Transfusion 2015;55:766–74.
82. Sparrow RL, Patton KA. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004;44:722–30.
83. Cardo LJ, Wilder D, Salata J. Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 2008;38:117–25.
84. Hendrickson JE, Hod EA, Hudson KE, et al. Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion 2011;51:2695–702.
85. Belizaire RM, Makley AT, Campion EM, et al. Resuscitation with washed aged packed red blood cell units decreases the proinflammatory response in mice after hemorrhage. J Trauma Acute Care Surg 2012;73:S128–33.
86. Patel MB, Proctor KG, Majetschak M. Extracellular ubiquitin increases in packed red blood cell units during storage. J Surg Res 2006;135:226–32.
87. Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010;115:4284–92.
88. Baumgartner JM, Silliman CC, Moore EE, et al. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg 2009;208:110–9.
89. Ghio M, Contini P, Negrini S, et al. Down regulation of human natural killer cell-mediated cytolysis induced by blood transfusion: role of transforming growth factor-β(1), soluble Fas ligand, and soluble Class I human leukocyte antigen. Transfusion 2011;51:1567–73.
90. Muszynski J, Nateri J, Nicol K, et al. Immunosuppressive effects of red blood cells on monocytes are related to both storage time and storage solution. Transfusion 2012;52:794–802.
91. Mynster T, Dybkjoer E, Kronborg G, et al. Immunomodulating effect of blood transfusion: is storage time important? Vox Sang 1998;74:176–81.
92. Ottonello L, Ghio M, Contini P, et al. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. Transfusion 2007;47:1395–404.
93. Long K, Meier C, Bernard A, et al. T-cell suppression by red blood cells is dependent on intact cells and is a consequence of blood bank processing. Transfusion 2014;54:1340–7.
94. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344–8.
95. Atzil S, Arad M, Glasner A, et al. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology 2008;109:989–97.
96. Cognasse F, Nguyen KA, Damien P, et al. The inflammatory role of platelets via their TLRs and Siglec receptors. Front Immunol 2015;6:83.
97. Stolla M, Refaai MA, Heal JM, et al. Platelet transfusion—the new immunology of an old therapy. Front Immunol 2015;6:28.
98. Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 2012;122:2661–71.
99. Loh YS, Johnson L, Kwok M, et al. Pathogen reduction treatment alters the immunomodulatory capacity of buffy coat-derived platelet concentrates. Transfusion 2014;54:577–84.
100. Aslam R, Speck ER, Kim M, et al. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC Class I molecules and is independent of white cells. Transfusion 2008;48:1778–86.
101. Perros AJ, Christensen AM, Flower RL, et al. Soluble mediators in platelet concentrates modulate dendritic cell inflammatory responses in an experimental model of transfusion. J Interferon Cytokine Res 2015;35:821–30.
102. Fast LD, DiLeone G, Marschner S. Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation. Transfusion 2011;51:1397–404.
103. Schneider SO, Rensing H, Gräber S, et al. Impact of platelets and fresh frozen plasma in contrast to red cell concentrate on unstimulated and stimulated cytokine release in an in vitro model of transfusion. Scand J Immunol 2009;70:101–5.
104. L'Acqua C, Bandyopadhyay S, Francis RO, et al. Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children. Am J Hematol 2015;90:915–20.
105. Keir AK, McPhee AJ, Andersen CC, et al. Plasma cytokines and markers of endothelial activation increase after packed red blood cell transfusion in the preterm infant. Pediatr Res 2013;73:75–9.
106. Fransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999;116:1233–9.
107. Bilgin YM, van de Watering LM, Versteegh MI, et al. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. Crit Care Med 2010;38:546–52.
108. Lin JS, Tzeng CH, Hao TC, et al. Cytokine release in febrile non-haemolytic red cell transfusion reactions. Vox Sang 2002;82:156–60.
109. Izbicki G, Rudensky B, Na'amad M, et al. Transfusion-related leukocytosis in critically ill patients. Crit Care Med 2004;32:439–42.
110. Locke R, Paul D, Touch S, et al. Cytokine load in prestorage leukoreduced PRBC transfusions in premature infants. J Perinatol 2005;25:526–30.
111. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011;118:6675–82.
112. Sitniakowsky LS, Later AF, van de Watering LM, et al. The effect of RBC transfusions on cytokine gene expression after cardiac surgery in patients developing post-operative multiple organ failure. Transfus Med 2011;21:236–46.
113. Theodoraki K, Markatou M, Rizos D, et al. The impact of two different transfusion strategies on patient immune response during major abdominal surgery: a preliminary report. J Immunol Res 2014;2014:945829.
114. Torrance HD, Vivian ME, Brohi K, et al. Changes in gene expression following trauma are related to the age of transfused packed red blood cells. J Trauma Acute Care Surg 2015;78:535–42.
115. Fragkou PC, Torrance HD, Pearse RM, et al. Perioperative blood transfusion is associated with a gene transcription profile characteristic of immunosuppression: a prospective cohort study. Crit Care 2014;18:541.
116. Bakkour S, Acker JP, Chafets DM, et al. Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells. Vox Sang 2016;111:22–32.
117. Hansen AL, Kurach JD, Turner TR, et al. The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 2015;108:350–8.
118. Jordan A, Chen D, Yi QL, et al. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang 2016;111:8–15.
119. Radwanski K, Garraud O, Cognasse F, et al. The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Transfusion 2013;53:3128–38.
120. Chasse M, McIntyre L, Tinmouth A, et al. Clinical effects of blood donor characteristics in transfusion recipients: protocol of a framework to study the blood donor-recipient continuum. BMJ Open 2015;5:e007412.
121. Spinella PC, Frazier E, Pidcoke HF, et al. All plasma products are not created equal: characterizing differences between plasma products. J Trauma Acute Care Surg 2015;78:S18–25.
122. Spitalnik SL, Triulzi D, Devine DV, et al. 2015 proceedings of the National Heart, Lung, and Blood Institute's state of the science in transfusion medicine symposium. Transfusion 2015;55:2282–90.